United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Merck to acquire Australian biotech firm Viralytics for $394m to bolster oncolytic immunotherapy treatments Significant Acquisition in Pharma Industry: US pharmaceutical giant Merck has announced a definitive agreement to acquire Viralytics, an… bySrinathFebruary 22, 2018
